| Targeting gastrin for the treatment of gastric acid related disorders and pancreatic cancer. | |
| | |
MedLine Citation:
|
PMID: 21397342 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Gastrin, acting through peripheral cholecystokinin (CCK) 2 receptors, is a major hormonal regulator of gastric acid secretion. The effects of gastrin on acid secretion occur both acutely and chronically because gastrin directly stimulates gastric acid secretion and also exerts trophic effects on the enterochromaffin-like and parietal cells that together constitute the acid secretory apparatus of the stomach. Several antagonists that target the CCK2 receptor have been identified and investigated for the treatment of gastroesophageal reflux disease and pancreatic cancer. In this paper, we discuss the contribution of gastrin to these disease pathologies and the data generated to date from clinical studies investigating CCK2 receptor antagonists. |
| | |
Authors:
|
Magda Morton; Clodagh Prendergast; Terrance D Barrett |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-3-10 |
Journal Detail:
|
Title: Trends in pharmacological sciences Volume: - ISSN: 1873-3735 ISO Abbreviation: - Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-3-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7906158 Medline TA: Trends Pharmacol Sci Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 3210 Merryfield Row, San Diego, CA 92121, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Analytical pharmacology: the impact of numbers on pharmacology.
Next Document: Experience-dependent structural plasticity in the cortex.